Podcast appearances and mentions of Michael J Overman

Featuring perspectives from Dr Michael J Overman, including the following topics: Introduction (0:00) Case: A woman in her mid 40s with microsatellite instability-high (MSI-H) colorectal adenocarcinoma metastatic to the brain receives pembrolizumab; KRAS G13D and somatic BRCA exon 11 mutations — Warren S Brenner, MD (16:27) Case: A woman in her late 50s with MSI-H Stage IIIB adenocarcinoma of the colon, BRAF V600E mutation — Eric H Lee, MD, PhD (23:20) Case: A woman in her early 70s with past medical history of diverticulitis and partial colectomy diagnosed with T1, microsatellite stable (MSS) cecal colon adenocarcinoma, minimum residual disease-negative after resection — Farshid Dayyani, MD, PhD (32:37) Case: A woman in her late 60s with past medical history of hypothyroidism has mass in right lung consistent with colorectal adenocarcinoma but no evidence of primary or other distant disease — Swati Vishwanathan, MD (42:58) Case: A woman in her mid 60s with multiregimen-relapsed RAS wild-type, HER2-positive metastatic rectal cancer, now receiving trastuzumab/tucatinib — Sunil Gandhi, MD (46:51) Case: A man in his mid 60s with MSS metastatic cecal adenocarcinoma and progressive disease on FOLFIRINOX/bevacizumab and capecitabine/bevacizumab maintenance — Dr Brenner (50:13) Case: A woman in her mid 60s with metastatic BRAF V600E-mutant colorectal adenocarcinoma, with circulating tumor DNA positivity after FOLFOX, heated intraperitoneal chemotherapy and colectomy/debulking surgery — Jeremy Lorber, MD (54:31) CME information and select publications

Featuring a discussion on the management of colorectal cancer with Dr Michael J Overman, moderated by Dr Neil Love.

Featuring a discussion on the management of colorectal cancer with Dr Michael J Overman, moderated by Dr Neil Love.

Featuring a discussion on the management of colorectal cancer with Dr Michael J Overman, moderated by Dr Neil Love.

In season 2, episode 6 of Targeted Talks, Dr. Michael J. Overman joins us for a special discussion around rare genomic alterations in colorectal cancer.

Host: Edward Chu, MD Guest: Michael J. Overman, MD Recent immunotherapy approvals have changed the treatment paradigm for first and subsequent lines of treatment for patients with microsatellite-high or mismatch repair deficient metastatic colorectal cancer. Join us as we deep dive into recent and newly emergent data to better understand how to bring these advances into the clinic.

Host: Edward Chu, MD Guest: Michael J. Overman, MD Recent immunotherapy approvals have changed the treatment paradigm for first and subsequent lines of treatment for patients with microsatellite-high or mismatch repair deficient metastatic colorectal cancer. Join us as we deep dive into recent and newly emergent data to better understand how to bring these advances into the clinic.

Oncology Today with Dr Neil Love: Colorectal Cancer Edition. Featuring a roundtable discussion with Drs Axel Grothey and Michael J Overman moderated by Neil Love, MD. Produced by Research To Practice.

Oncology Today with Dr Neil Love: Colorectal Cancer Edition. Featuring a roundtable discussion with Drs Axel Grothey and Michael J Overman moderated by Neil Love, MD. Produced by Research To Practice.

Cathy Eng, MD, Professor in Gastrointestinal Medical Oncology at MD Anderson Cancer Center, introduces her Physicians Network Symposium session: "GI Tumors Novel Discoveries and Future of Research" including the following talks: The Role of Immunotherapy in Esophageal and Gastric Malignancies - Mariela Blum Murphy, MD; Advances and Future Directions in the Management of Biliary Malignancies - Rachna Shroff, MD; New Therapeutic Options for Neuroendocrine Tumors - Arvind Dasari, MD; Does Immunotherapy Have a Role in Colorectal Cancer? - Michael J. Overman, MD; Research Directions in Cancers of the Anal Canal - Cathy Eng, MD.